USPTO serial 99803223
PROLIFIC
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- BURCHAM, NATHAN D
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PROLIFIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Emeryville, CA, US
Emeryville, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Aaron D. Hendelman
Aaron D. Hendelman Wilson Sonsini Goodrich & Rosati650 Page Mill RoadPalo Alto, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Proteins for use in manufacture; Cell culture reagents for scientific or research purposes; Cell culture media for use in biomanufacturing processes | ACTIVE | — |
| 005 | Therapeutic vaccines; Antibodies for medical purposes; Therapeutic antibodies for human use for the treatment of cancer, autoimmune disorders, infections, and metabolic disorders; Pharmaceutical preparations for gene therapy for the treatment of cancer, autoimmune disorders, infections, and metabolic disorders; Biological preparations for use in cell cultures for medical purposes; Cell culture media for medical purposes | ACTIVE | — |
| 040 | Custom biomanufacturing of pharmaceuticals containing cultured cells for use in cell therapy; Custom biomanufacturing of pharmaceuticals containing cultured cells for use in gene therapy | ACTIVE | — |
| 042 | Development of pharmaceuticals for cell and gene therapies; Research and development in the field of therapeutic proteins; Research and development in the field of antibodies, vaccines, cell therapies, and gene therapies; Research and development in the field of optogenetics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Prolific Machines, Inc.
- Other trademarks owned by Prolific Machines, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PROLIFIC
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 1, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 3, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 4, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2026 | NWAP | NEW APPLICATION ENTERED | — |